74
Participants
Start Date
March 29, 2022
Primary Completion Date
May 28, 2024
Study Completion Date
May 28, 2024
Bemarituzumab
Intravenous (IV) infusion
Docetaxel
IV infusion
Pembrolizumab
IV infusion
Carboplatin
IV infusion
Paclitaxel
IV infusion
Nab-paclitaxel
IV infusion
Cliniques Universitaires Saint Luc, Brussels
Universitair Ziekenhuis Antwerpen, Edegem
Jessa Ziekenhuis - Campus Virga Jesse, Hasselt
Universitair Ziekenhuis Gent, Ghent
Montefiore Einstein Center for Cancer Care, The Bronx
Taipei Veterans General Hospital, Taipei
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do
Complexo Hospitalario Universitario A Coruña Hospital Teresa Herrera, A Coruña
University of Pittsburgh, Cancer Institute, Pittsburgh
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Hospital Regional Universitario de Malaga, Málaga
Institut Bergonie, Bordeaux
Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation, Taoyuan District
Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes
Hospital Universitario Virgen del Rocio, Seville
CHU de Lyon - Hopital Louis Pradel, Bron
National Cheng Kung University Hospital, Tainan City
Hôpital Tenon, Paris
Centre Hospitalier Universitaire de Poitiers - Hopital la Miletrie, Poitiers
University of California Irvine, Orange
Institut Gustave Roussy, Villejuif
Morristown Medical Center, Morristown
National Cancer Center Hospital East, Kashiwa-shi
Shizuoka Cancer Center, Sunto-gun
Wakayama Medical University Hospital, Wakayama
Przychodnia Lekarska Komed Roman Karaszewski, Konin
Pratia Mcm Krakow, Krakow
Krakowskie Centrum Medyczne Sp zoo, Krakow
Instytut Centrum Zdrowia Matki Polki, Lodz
Instytut Genetyki i Immunologii GENIM Spzoo, Lublin
Centrum Medyczne Hope Clinic Sebastian Szklener, Lublin
Mazowieckie centrum leczenia, Otwock
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Hospital Universitari Vall d Hebron, Barcelona
Hospital Clinic i Provincial de Barcelona, Barcelona
Institut Catala d Oncologia Hospitalet. Hospital Duran i Reynals, L'Hospitalet de Llobregat
Lead Sponsor
Amgen
INDUSTRY